reference/5349603

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5349603

Outgoing Links

Predicate	Object
contentType	Clinical Trial Protocol\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	15
issn	1551-7144
pageRange	8-15
publicationName	Contemporary Clinical Trials
startingPage	8
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e9f6f54b3a7b60c50e13881620463d90 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d0ed60b8233e19de95ed1094939c3477 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fa692fa31ab7b0a951b395b4718a6684 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8a84060532d8b9418fd17a2962a3d068 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c723879df57790a6c68f1f180b942f5e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_68ec7025bedae759490c8c323c5232c8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0db5657442f7f27e74b42967a29dae44 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_875fa1005cd27e37135bb4bf4c9d6b80 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_caa8af765a22e7ef679109d087fad62a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e573d9ee7cf3f1c169c9a4dfc4fe5068 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2ba503f79a9d3a27ccda735e10833db9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4a5bf0b8c6a3e66e89be27f96175348e
bibliographicCitation	Back SE, Flanagan JC, Jones JL, Augur I, Peterson AL, Young-McCaughan S, Shirley DW, Henschel A, Joseph JE, Litz BT, Hancock AK, Roache JD, Mintz J, Wachen JS, Keane TM, Brady KT; Consortium to Alleviate PTSD. Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans. Contemp Clin Trials. 2018 Oct;73():8–15. PMID: 30145268; PMCID: PMC6291829.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15f63f6062c8040dd928f8622560db77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c9b95751425c02e24275ac7705cbdea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20519adacda25a9461c87feac0ee53da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4db4f556ac67d72a68380460871d82d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c18cddeaecfcd97e468f9858f7423a1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87776f4c23076e4013d56a1fb2afff1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_116cc6e603d15804f7b9799e7045ef07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_516b066cc59e339da60a9941697f256b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e04a4035ad29c535377be9ab1ae3e212 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e50467c4cd35babefc3db1dfb45b8c42 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef09e3373ea8235e2623e4e6377acd99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94ef62ca35cbc1ee9a760826d9dc6dc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f9ec63d3d2639900c9f71ada440d93e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a32db5c6a879adbc8431cbde916a3ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66678ea8b8994b8d56f8f25e04e369f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24700d5ee3107930cd21d91b44b34dff
date	201810
identifier	https://pubmed.ncbi.nlm.nih.gov/30145268 https://doi.org/10.1016/j.cct.2018.08.009 https://pubmed.ncbi.nlm.nih.gov/PMC6291829
isPartOf	https://portal.issn.org/resource/ISSN/1551-7144 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32406
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans
discusses	http://id.nlm.nih.gov/mesh/M0543996 http://id.nlm.nih.gov/mesh/M0026251
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014728 http://id.nlm.nih.gov/mesh/D017292Q000627 http://id.nlm.nih.gov/mesh/D000437Q000523 http://id.nlm.nih.gov/mesh/D000437Q000000981 http://id.nlm.nih.gov/mesh/D013313Q000000981 http://id.nlm.nih.gov/mesh/D013313Q000188 http://id.nlm.nih.gov/mesh/D058668Q000627 http://id.nlm.nih.gov/mesh/D000437Q000188 http://id.nlm.nih.gov/mesh/D013313Q000523
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001921Q000000981 http://id.nlm.nih.gov/mesh/D017322 http://id.nlm.nih.gov/mesh/D008279 http://id.nlm.nih.gov/mesh/D059907 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6842 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9315 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3157 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923

Showing number of triples: 1 to 72 of 72.